Cargando…
HIF1α is not a target of 14q deletion in clear cell renal cancer
HIF1α has been termed a tumor-suppressor in clear cell renal cell carcinoma (ccRCC), primarily based on functional proliferation studies in cell lines (in vitro and in vivo) with genetic manipulation, and the adverse prognosis of 14q-deleted ccRCC patients. In other malignancies, however, HIF1α has...
Autor principal: | Shenoy, Niraj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573601/ https://www.ncbi.nlm.nih.gov/pubmed/33077781 http://dx.doi.org/10.1038/s41598-020-74631-7 |
Ejemplares similares
-
Opposite prognostic roles of HIF1α and HIF2α expressions in bone metastatic clear cell renal cell cancer
por: Szendrői, Attila, et al.
Publicado: (2016) -
HIF-1α and HIF-2α differently regulate tumour development and inflammation of clear cell renal cell carcinoma in mice
por: Hoefflin, Rouven, et al.
Publicado: (2020) -
Effects of HIF-1α and HIF2α on Growth and Metabolism of Clear-Cell Renal Cell Carcinoma 786-0 Xenografts
por: Biswas, Swethajit, et al.
Publicado: (2010) -
Link between dysregulated hypoxia signaling and aberrant methylation in clear cell renal cell carcinoma?
por: Shenoy, Niraj
Publicado: (2017) -
Targeting HIF2α Translation with Tempol in VHL-Deficient Clear Cell Renal Cell Carcinoma
por: Sourbier, Carole, et al.
Publicado: (2012)